Significant Response to Integrated Yoga and Naturopathy Therapies in Post-COVID-19 Neuropathy: A Case Report.

Background: The Coronavirus disease (COVID-19) pandemic has been accompanied by a diverse array of neurologic complications attributed to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. These complications vary widely, encompassing symptoms such as fatigue, headaches, concentration disturbances, and polyneuropathy-related complaints. Considering the multifaceted nature of these neurological manifestations, exploring alternative and complementary treatment modalities, such as integrated Yoga and Naturopathy interventions, is crucial for enhancing patient outcomes and quality of life. This case report delves into the potential efficacy of such interventions in managing post-COVID neurological complications.

Case presentation: A 60-year-old male patient presented with peripheral sensory and motor disturbances following a COVID-19 infection. He experienced symptoms such as numbness, pain, and difficulty gripping objects in his right upper limb, emerging 12 weeks after contracting the virus. Clinical examination revealed hypoesthesia and pallhypesthesia in the affected hand. After the onset of neurological symptoms, the patient underwent a 14-day integrated regimen of Yoga and Naturopathy interventions. Clinical and electrophysiological examinations, including nerve conduction studies and grip strength measurements, were conducted before and after the intervention period.

Results: After the 14-day integrated Yoga and Naturopathy intervention, the patient demonstrated notable improvements in both subjective and objective measures of neurological symptoms. These improvements suggest a positive response to the treatment regimen and underscore the potential efficacy of integrated, holistic approaches in alleviating post-COVID neurological complications.

Conclusion: These findings suggest a potential role for integrated Yoga and Naturopathy as effective complementary modalities in managing post-COVID neurological sequelae. However, further empirical studies are warranted to corroborate these findings and explain the broader therapeutic benefits of such interventions in the context of post-COVID-19 disease.